We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-8.09%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$176M
AUM Growth
-$66.3M
Cap. Flow
-$43.6M
Cap. Flow %
-24.78%
Top 10 Hldgs %
39.96%
Holding
51
New
2
Increased
12
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$3.98M
2
A icon
Agilent Technologies
A
+$3.69M
3
LLY icon
Eli Lilly
LLY
+$3.45M
4
SYK icon
Stryker
SYK
+$2.47M
5
NVO
Novo Nordisk
NVO
+$1.66M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$7.51M
2
CVS icon
CVS Health
CVS
+$6.07M
3
LH icon
Labcorp
LH
+$5.27M
4
GMED icon
Globus Medical
GMED
+$4.8M
5
CYH icon
Community Health Systems
CYH
+$3.56M

Sector Composition

Rank Sector Weight
1 Healthcare 96.12%
2 Energy 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVST icon
51
Envista
NVST
$4.61B
– –
-60,000
Closed -$2.92M
1 2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return
CIP
Castlefield Investment Partners Manchester $131M AUM

Sivik Global Healthcare's Q2 2022 Portfolio in Review

As of Q2 2022, Sivik Global Healthcare held 51 positions worth $176M, down 27% from $242M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sivik Global Healthcare withdrew a net $43.6M in Q2 2022, closing 13 positions and reducing 17 holdings. Its most notable exit was CVS Health, an estimated $6.07M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 93% a quarter earlier, followed by Energy.

Against the trend, Sivik Global Healthcare opened a new position in Sanofi worth $3.75M.

  • Sivik Global Healthcare's largest Q2 2022 buy was Sanofi: 75,000 shares worth $3.75M.
  • Sivik Global Healthcare added most to Eli Lilly in Q2 2022, an estimated $3.45M increase.
  • Sivik Global Healthcare's biggest Q2 2022 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $7.51M.
  • Sivik Global Healthcare fully exited CVS Health in Q2 2022, selling an estimated $6.07M.
  • Sivik Global Healthcare's ten largest holdings make up 40% of its $176M portfolio in Q2 2022.
  • Sivik Global Healthcare opened 2 new positions and closed 13 in Q2 2022.
  • Sivik Global Healthcare's portfolio value fell 27% quarter-over-quarter to $176M.

Based on Sivik Global Healthcare's 13F filing for Q2 2022, filed 10 Aug 2022.